Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank43
3Y CAGR-13.3%
5Y CAGR-14.8%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-13.3%/yr
vs -29.1%/yr prior
5Y CAGR
-14.8%/yr
Consistent
Acceleration
+15.8pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.03 | +9.1% |
| 2024 | 0.03 | -55.8% |
| 2023 | 0.06 | +35.1% |
| 2022 | 0.04 | -43.9% |
| 2021 | 0.08 | +22.6% |
| 2020 | 0.06 | +233.8% |
| 2019 | 0.02 | -89.0% |
| 2018 | 0.17 | -10.6% |
| 2017 | 0.19 | +595.2% |
| 2016 | 0.03 | - |